Zimmer Biomet Holdings (ZBH) Enterprise Value (2009 - 2026)
Zimmer Biomet Holdings' (ZBH) quarterly Enterprise Value came in at -$416.0 million in Q1 2026, up 69.76% year-on-year from -$245.0 million in Q1 2025, and up 28.74% quarter-over-quarter from -$583.8 million in Q4 2025.
Zimmer Biomet Holdings (ZBH) Enterprise Value (2009 - 2026) Analysis & Trends
Zimmer Biomet Holdings' Enterprise Value history runs 18 years deep, the most recent figure standing at -$416.0 million for Q1 2026.
- On a quarterly basis, Enterprise Value rose 69.76% year-over-year to -$416.0 million in Q1 2026; TTM through Mar 2026 was -$416.0 million, a 69.76% increase from a year earlier, with the FY2025 full-year figure at -$583.8 million, down 12.83% from the prior year.
- Enterprise Value improved to -$416.0 million in Q1 2026 per ZBH's latest filing, from -$583.8 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$284.9 million in Q3 2023 and bottomed at -$1.4 billion in Q1 2025.
- The 5-year median for Enterprise Value is -$416.0 million (2026), against an average of -$536.9 million.
- Across the five-year window, Enterprise Value tumbled 257.44% in 2025 and soared 69.76% in 2026, its largest moves.
- Year by year, Enterprise Value stood at -$369.0 million in 2022, then declined by 10.6% to -$408.1 million in 2023, then slipped by 26.78% to -$517.4 million in 2024, then fell by 12.83% to -$583.8 million in 2025, then rose by 28.74% to -$416.0 million in 2026.
- Per Business Quant, the three latest ZBH Enterprise Value figures stand at -$416.0 million (Q1 2026), -$583.8 million (Q4 2025), and -$1.3 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.26 Bn | 175.96 Bn | 6.27 Bn | -6.66 Bn |
| 2 | Stryker | 128.79 Bn | 125.92 Bn | 3.81 Bn | -2.88 Bn |
| 3 | Medtronic | 108.56 Bn | 99.34 Bn | 6.41 Bn | -8.61 Bn |
| 4 | Boston Scientific | 68.31 Bn | 66.86 Bn | 3.61 Bn | -1.21 Bn |
| 5 | Edwards Lifesciences | 47.27 Bn | 43.60 Bn | 1.29 Bn | -3.67 Bn |
| 6 | Dexcom | 28.42 Bn | 27.31 Bn | 750.30 Mn | -1.12 Bn |
| 7 | GE HealthCare Technologies | 28.40 Bn | 26.12 Bn | 1.98 Bn | -2.07 Bn |
| 8 | Smith & Nephew | 26.95 Bn | 26.37 Bn | - | -577.00 Mn |
| 9 | Koninklijke Philips | 25.52 Bn | 22.40 Bn | 2.07 Bn | -3.09 Bn |
| 10 | Zimmer Biomet Holdings | 18.07 Bn | 17.65 Bn | 1.51 Bn | -416.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -416.00 Mn |
| Dec 31, 2025 | -583.80 Mn |
| Sep 30, 2025 | -1.28 Bn |
| Jun 30, 2025 | -547.60 Mn |
| Mar 31, 2025 | -1.38 Bn |
| Dec 31, 2024 | -517.40 Mn |
| Sep 30, 2024 | -560.50 Mn |
| Jun 30, 2024 | -411.70 Mn |
| Mar 31, 2024 | -384.90 Mn |
| Dec 31, 2023 | -408.10 Mn |
| Sep 30, 2023 | -284.90 Mn |
| Jun 30, 2023 | -312.70 Mn |
| Mar 31, 2023 | -323.30 Mn |
| Dec 31, 2022 | -369.00 Mn |
| Sep 30, 2022 | -539.00 Mn |
| Jun 30, 2022 | -380.20 Mn |
| Mar 31, 2022 | -429.90 Mn |
| Dec 31, 2021 | -372.40 Mn |
| Sep 30, 2021 | -914.00 Mn |
| Jun 30, 2021 | -1.04 Bn |